L-glutamine for preventing painful crises in sickle cell disease in people aged 5 years and over [ID1523]
Discontinued
Reference number: GID-TA10452
Following on from information provided to NICE by the company in June 2019, the appraisal of L-glutamine for treating sickle cell disease [ID1523] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.